KLRG1 Cell Depletion as a Novel Therapeutic Strategy in Patients with Mature T-Cell Lymphoma Subtypes.

Autor: Assatova B; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Willim R; Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Trevisani C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; College of Medicine, SUNY Upstate Medical University, Syracuse, New York., Haskett G; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Kariya KM; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts., Chopra K; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts., Park SR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Tolstorukov MY; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., McCabe SM; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts., Duffy J; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts., Louissaint A Jr; Harvard Medical School, Boston, Massachusetts.; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts., Huuhtanen J; Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland., Bhattacharya D; Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland., Mustjoki S; Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland., Koh MJ; School of Medicine, Georgetown University, Washington, District of Columbia., Powers F; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, University of Minnesota, Minneapolis, Minnesota., Morgan EA; Harvard Medical School, Boston, Massachusetts.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., Yang L; MD Anderson UTH Health Graduate School of Biomedical Sciences, Houston, Texas., Pinckney B; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Cotton MJ; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Crabbe A; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts.; Department of Pathology, Akron General, Cleveland Clinic, Akron, Ohio., Ziemba JB; Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.; Histopath, Inc, Corpus Christi, Texas., Brain I; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada., Heavican-Foral TB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Iqbal J; Department of Pathology and Microbiology, College of Medicine, University of Nebraska Medical Center, Omaha, Nebraska., Nemec R; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts., Rider AB; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts., Ford JG; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts., Koh MJ; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts., Scanlan N; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts., Feith DJ; Department of Medicine, University of Virginia Cancer Center, University of Virginia School of Medicine, Charlottesville, Virginia., Loughran TP Jr; Department of Medicine, University of Virginia Cancer Center, University of Virginia School of Medicine, Charlottesville, Virginia., Kim WS; Department of Medicine, Sungkyunkwan University, Samsung Medical Center, Seoul, South Korea., Choi J; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois., Roels J; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium., Boehme L; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium., Putteman T; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium., Taghon T; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium., Barnes JA; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Johnson PC; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Jacobsen ED; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Greenberg SA; Harvard Medical School, Boston, Massachusetts.; Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts., Weinstock DM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Broad Institute of Harvard and MIT, Cambridge, Massachusetts., Jain S; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Jun 03; Vol. 30 (11), pp. 2514-2530.